AbbVie Common Stock Shares Outstanding from 2010 to 2024

ABBV Stock  USD 171.73  3.97  2.37%   
AbbVie Common Stock Shares Outstanding yearly trend continues to be fairly stable with very little volatility. Common Stock Shares Outstanding is likely to outpace its year average in 2024. Common Stock Shares Outstanding is the total number of shares of a company's common stock that are currently owned by all its shareholders. View All Fundamentals
 
Common Stock Shares Outstanding  
First Reported
2011-03-31
Previous Quarter
1.8 B
Current Value
1.8 B
Quarterly Volatility
96.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.1 B, Interest Expense of 1.1 B or Selling General Administrative of 7.8 B, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0289 or PTB Ratio of 17.2. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Common Stock Shares Outstanding Growth Pattern

Below is the plot of the Common Stock Shares Outstanding of AbbVie Inc over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. AbbVie's Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
Common Stock Shares Outstanding10 Years Trend
Slightly volatile
   Common Stock Shares Outstanding   
       Timeline  

AbbVie Common Stock Shares Outstanding Regression Statistics

Arithmetic Mean1,649,643,556
Geometric Mean1,647,186,928
Coefficient Of Variation5.67
Mean Deviation73,924,741
Median1,625,000,000
Standard Deviation93,569,618
Sample Variance8755.3T
Range317.7M
R-Value0.62
Mean Square Error5829.5T
R-Squared0.38
Significance0.01
Slope12,927,048
Total Sum of Squares122573.8T

AbbVie Common Stock Shares Outstanding History

20241.8 B
20231.8 B
20221.8 B
20211.8 B
20201.7 B
20191.5 B
20181.5 B

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Shares Outstanding1.8 B1.8 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.